C12N 2501/83
Tachykinins
Official title: Tachykinins, e.g. substance P
C12N2501/83 (Tachykinins) appears on 0 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 0
- Published applications
- 9
- Assignees
- 4
- Inventors
- 13
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Composition for promoting production of stem cell-derived exosomes and increasing stemness27 Feb 2025US 2025/0066721 A1Brexogen Inc.
- Composition for promoting production of stem cell-derived exosomes and increasing stemness23 Jun 2022US 2022/0195384 A1Brexogen Inc.
- Methods and Compositions for Stimulating the Proliferation or Differentiation of Stem Cells with Substance Por an Analog Thereof10 Jun 2010US 2010/0143477 A1ImmuneRegen Biosciences, Inc.
- Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof29 Jan 2009US 2009/0028834 A1
- Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells7 Dec 2006US 2006/0275900 A1Becton, Dickinson and Company
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.